AAAAAA

   
Results: 1-14 |
Results: 14
ESTROGEN BLOCKS M-CSF GENE-EXPRESSION AND OSTEOCLAST FORMATION BY REGULATING PHOSPHORYLATION OF EGR-1 AND ITS INTERACTION WITH SP-1
Authors: SRIVASTAVA S WEITZMANN MN KIMBLE RB RIZZO M ZAHNER M MILBRANDT J ROSS FP PACIFICI R
Citation: S. Srivastava et al., ESTROGEN BLOCKS M-CSF GENE-EXPRESSION AND OSTEOCLAST FORMATION BY REGULATING PHOSPHORYLATION OF EGR-1 AND ITS INTERACTION WITH SP-1, The Journal of clinical investigation, 102(10), 1998, pp. 1850-1859
THE FUNCTIONAL BLOCK OF TNF BUT NOT OF IL-6 PREVENTS BONE LOSS IN OVARIECTOMIZED MICE
Authors: KIMBLE RB BAIN S PACIFICI R
Citation: Rb. Kimble et al., THE FUNCTIONAL BLOCK OF TNF BUT NOT OF IL-6 PREVENTS BONE LOSS IN OVARIECTOMIZED MICE, Journal of bone and mineral research, 12(6), 1997, pp. 935-941
ESTROGEN INHIBITS MACROPHAGE TNF GENE-EXPRESSION BY MODULATING BINDING OF TRANSCRIPTION FACTORS TO THE AP-1 BINDING-SITE
Authors: KIMBLE RB SRIVASTAVA S PACIFICI R
Citation: Rb. Kimble et al., ESTROGEN INHIBITS MACROPHAGE TNF GENE-EXPRESSION BY MODULATING BINDING OF TRANSCRIPTION FACTORS TO THE AP-1 BINDING-SITE, Journal of bone and mineral research, 12, 1997, pp. 353-353
ALCOHOL, CYTOKINES, AND ESTROGEN IN THE CONTROL OF BONE REMODELING
Authors: KIMBLE RB
Citation: Rb. Kimble, ALCOHOL, CYTOKINES, AND ESTROGEN IN THE CONTROL OF BONE REMODELING, Alcoholism, clinical and experimental research, 21(3), 1997, pp. 385-391
ESTROGEN INHIBITS IL-1 AND TNF GENE-EXPRESSION IN TRANSFECTED MURINE MACROPHAGIC CELLS
Authors: KIMBLE RB SRIVASTAVA S BELLONE C PACIFICI R
Citation: Rb. Kimble et al., ESTROGEN INHIBITS IL-1 AND TNF GENE-EXPRESSION IN TRANSFECTED MURINE MACROPHAGIC CELLS, Journal of bone and mineral research, 11, 1996, pp. 235-235
ESTROGEN DEFICIENCY INCREASES THE ABILITY OF STROMAL CELLS TO SUPPORTMURINE OSTEOCLASTOGENESIS VIA AN INTERLEUKIN-1-MEDIATED AND TUMOR NECROSIS FACTOR-MEDIATED STIMULATION OF MACROPHAGE-COLONY-STIMULATING FACTOR PRODUCTION
Authors: KIMBLE RB SRIVASTAVA S ROSS FP MATAYOSHI A PACIFICI R
Citation: Rb. Kimble et al., ESTROGEN DEFICIENCY INCREASES THE ABILITY OF STROMAL CELLS TO SUPPORTMURINE OSTEOCLASTOGENESIS VIA AN INTERLEUKIN-1-MEDIATED AND TUMOR NECROSIS FACTOR-MEDIATED STIMULATION OF MACROPHAGE-COLONY-STIMULATING FACTOR PRODUCTION, The Journal of biological chemistry, 271(46), 1996, pp. 28890-28897
INHIBITION OF IL-6 ACTIVITY IN GENETICALLY NORMAL MICE DOES NOT PREVENT OVARIECTOMY-INDUCED BONE LOSS
Authors: KIMBLE RB BAIN SD KUNG V PACIFICI R
Citation: Rb. Kimble et al., INHIBITION OF IL-6 ACTIVITY IN GENETICALLY NORMAL MICE DOES NOT PREVENT OVARIECTOMY-INDUCED BONE LOSS, Journal of bone and mineral research, 10, 1995, pp. 160-160
BONE QUALITY FACTOR (BQF) ANALYSIS, A NEW ULTRA SENSITIVE TECHNIQUE FOR THE DETECTION OF BONE LOSS - A COMPARATIVE-STUDY WITH DEXA IN OVARIECTOMIZED RATS
Authors: ABBASIJAHROMI SH MATAYOSHI AB KIMBLE RB DIMAROGONAS AD PACIFICI R
Citation: Sh. Abbasijahromi et al., BONE QUALITY FACTOR (BQF) ANALYSIS, A NEW ULTRA SENSITIVE TECHNIQUE FOR THE DETECTION OF BONE LOSS - A COMPARATIVE-STUDY WITH DEXA IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 477-477
SIMULTANEOUS BLOCK OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR IS REQUIRED TO COMPLETELY PREVENT BONE LOSS IN THE EARLY POSTOVARIECTOMY PERIOD
Authors: KIMBLE RB MATAYOSHI AB VANNICE JL KUNG VT WILLIAMS C PACIFICI R
Citation: Rb. Kimble et al., SIMULTANEOUS BLOCK OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR IS REQUIRED TO COMPLETELY PREVENT BONE LOSS IN THE EARLY POSTOVARIECTOMY PERIOD, Endocrinology, 136(7), 1995, pp. 3054-3061
PERSISTENT BONE-SPARING EFFECT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST -A HYPOTHESIS ON THE ROLE OF IL-1 IN OVARIECTOMY-INDUCED BONE LOSS
Authors: KIMBLE RB KITAZAWA R VANNICE JL PACIFICI R
Citation: Rb. Kimble et al., PERSISTENT BONE-SPARING EFFECT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST -A HYPOTHESIS ON THE ROLE OF IL-1 IN OVARIECTOMY-INDUCED BONE LOSS, Calcified tissue international, 55(4), 1994, pp. 260-265
INTERLEUKIN-1 RECEPTOR ANTAGONIST AND TUMOR-NECROSIS-FACTOR BINDING-PROTEIN DECREASE OSTEOCLAST FORMATION AND BONE-RESORPTION IN OVARIECTOMIZED MICE
Authors: KITAZAWA R KIMBLE RB VANNICE JL KUNG VT PACIFICI R
Citation: R. Kitazawa et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST AND TUMOR-NECROSIS-FACTOR BINDING-PROTEIN DECREASE OSTEOCLAST FORMATION AND BONE-RESORPTION IN OVARIECTOMIZED MICE, The Journal of clinical investigation, 94(6), 1994, pp. 2397-2406
INTERLEUKIN-1 RECEPTOR ANTAGONIST DECREASES BONE LOSS AND BONE-RESORPTION IN OVARIECTOMIZED RATS
Authors: KIMBLE RB VANNICE JL BLOEDOW DC THOMPSON RC HOPFER W KUNG VT BROWNFIELD C PACIFICI R
Citation: Rb. Kimble et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST DECREASES BONE LOSS AND BONE-RESORPTION IN OVARIECTOMIZED RATS, The Journal of clinical investigation, 93(5), 1994, pp. 1959-1967
IL-1 RECEPTOR ANTAGONIST (IL-1RA) BLOCKS BONE LOSS IN OVARIECTOMIZED RATS BY DECREASING BONE-RESORPTION
Authors: KIMBLE RB HOPFER W BROWNFIELD C VANNICE JL KUNG V PACIFICI R
Citation: Rb. Kimble et al., IL-1 RECEPTOR ANTAGONIST (IL-1RA) BLOCKS BONE LOSS IN OVARIECTOMIZED RATS BY DECREASING BONE-RESORPTION, Journal of bone and mineral research, 8, 1993, pp. 190000122-190000122
MONOCYTIC SECRETION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN NORMAL AND OSTEOPOROTIC WOMEN - EFFECTS OF MENOPAUSE AND ESTROGEN PROGESTERONE THERAPY/
Authors: PACIFICI R VANNICE JL RIFAS L KIMBLE RB
Citation: R. Pacifici et al., MONOCYTIC SECRETION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN NORMAL AND OSTEOPOROTIC WOMEN - EFFECTS OF MENOPAUSE AND ESTROGEN PROGESTERONE THERAPY/, The Journal of clinical endocrinology and metabolism, 77(5), 1993, pp. 1135-1141
Risultati: 1-14 |